FDA clears digital therapeutic for abdominal pain from IBS
MetaMe received FDA clearance for its first digital therapeutic on Tuesday. It uses behavioral therapy to help alleviate abdominal pain symptoms for patients with irritable bowel syndrome.
MetaMe raises $3.8M to create a hypnosis-based DTX for your IBS
The company's lead product Regulora delivers a standardized 12-week therapy which bring patients into a state of deep relaxation and suggestibility before using metaphors and stories to create a sense of comfort and ease around the individual's condition and symptoms.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.